15 min listen
NEJM Interview: Interview with Professor Kevin Outterson on the FDA’s guidance on off-label promotion and the move toward clinical trial transparency.
FromNEJM Interviews
NEJM Interview: Interview with Professor Kevin Outterson on the FDA’s guidance on off-label promotion and the move toward clinical trial transparency.
FromNEJM Interviews
ratings:
Length:
9 minutes
Released:
Jul 2, 2014
Format:
Podcast episode
Description
Kevin Outterson is a professor of health law, bioethics, and human rights at the Boston University School of Law. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. K. Outterson. Clinical Trial Transparency - Antidote to Weaker Off-Label-Promotion Rules? N Engl J Med 2014;371:1-3.
Released:
Jul 2, 2014
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Dr. Jerry Avorn on the evolving approach to drug safety in the United States by NEJM Interviews